Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats

Salvatore Cuzzocrea, Emanuela Mazzon, Carla Bevilaqua, Giuseppina Costantino, Domenico Britti, Giuseppe Mazzullo, Angela De Sarro, Achille P. Caputi

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

1. The aim of the present stud), was to investigate the effects of cloricromene, a coumarine derivative, in rats subjected to collagen-induced arthritis. 2. Collagen-induced arthritis (CIA) was induced in Lewis rats by an intradermal injection of 100 μl of the emulsion (containing 100 μg of bovine type II collagen) (CII) and complete Freund's adjuvant (CFA) at the base of the tail. On day 21, a second injection of CII in CFA was administered. 3. Lewis rats developed an erosive hind paw arthritis when immunized with CII in CFA. Macroscopic clinical evidence of CIA first appeared as peri-articular erythema and oedema in the hind paws. The incidence of CIA was 100% by day 27 in the CII challenged rats and the severity of CIA progressed over a 35-day period with radiographic evaluation revealing focal resorption of bone together with osteophyte formation in the tibiotarsal joint and soft tissue swelling. 4. The histopathology of CIA included erosion of the cartilage at the joint margins. Treatment of rats with cloricromene (10 mg kg -1 i.p. daily) starting at the onset of arthritis (day 23), delayed the development of the clinical signs at days 24-35 and improved histological status in the knee and paw. 5. Immunohistochemical analysis for iNOS, COX-2, nitrotyrosine and for poly (ADP-ribose) synthetase (PARS) revealed a positive staining in inflamed joints from collagen-treated rats. The degree of staining for iNOS, COX-2, nitrotyrosine and PARS were markedly reduced in tissue sections obtained from collagen-treated rats, which had received cloricromene. 6. Radiographic signs of protection against bone resorption and osteophyte formation were present in the joints of cloricromene-treated rat. 7. This study provides the first evidence that cloricromene, a coumarine derivative, attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in the rat.

Original languageEnglish
Pages (from-to)1399-1407
Number of pages9
JournalBritish Journal of Pharmacology
Volume131
Issue number7
Publication statusPublished - 2000

Fingerprint

Coumarins
Experimental Arthritis
Joints
Freund's Adjuvant
Poly Adenosine Diphosphate Ribose
Osteophyte
Ligases
Bone Resorption
Arthritis
Collagen
Staining and Labeling
cloricromen
Intradermal Injections
Collagen Type II
Erythema
Emulsions
Cartilage
Tail
Edema
Knee

Keywords

  • Cloricromene
  • Collagen
  • COX-2
  • Inflammation
  • Nitric oxide
  • Peroxynitrite
  • TNFα

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cuzzocrea, S., Mazzon, E., Bevilaqua, C., Costantino, G., Britti, D., Mazzullo, G., ... Caputi, A. P. (2000). Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. British Journal of Pharmacology, 131(7), 1399-1407.

Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. / Cuzzocrea, Salvatore; Mazzon, Emanuela; Bevilaqua, Carla; Costantino, Giuseppina; Britti, Domenico; Mazzullo, Giuseppe; De Sarro, Angela; Caputi, Achille P.

In: British Journal of Pharmacology, Vol. 131, No. 7, 2000, p. 1399-1407.

Research output: Contribution to journalArticle

Cuzzocrea, S, Mazzon, E, Bevilaqua, C, Costantino, G, Britti, D, Mazzullo, G, De Sarro, A & Caputi, AP 2000, 'Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats', British Journal of Pharmacology, vol. 131, no. 7, pp. 1399-1407.
Cuzzocrea S, Mazzon E, Bevilaqua C, Costantino G, Britti D, Mazzullo G et al. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. British Journal of Pharmacology. 2000;131(7):1399-1407.
Cuzzocrea, Salvatore ; Mazzon, Emanuela ; Bevilaqua, Carla ; Costantino, Giuseppina ; Britti, Domenico ; Mazzullo, Giuseppe ; De Sarro, Angela ; Caputi, Achille P. / Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. In: British Journal of Pharmacology. 2000 ; Vol. 131, No. 7. pp. 1399-1407.
@article{da5437f4aa584a6999e382bf805cca2c,
title = "Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats",
abstract = "1. The aim of the present stud), was to investigate the effects of cloricromene, a coumarine derivative, in rats subjected to collagen-induced arthritis. 2. Collagen-induced arthritis (CIA) was induced in Lewis rats by an intradermal injection of 100 μl of the emulsion (containing 100 μg of bovine type II collagen) (CII) and complete Freund's adjuvant (CFA) at the base of the tail. On day 21, a second injection of CII in CFA was administered. 3. Lewis rats developed an erosive hind paw arthritis when immunized with CII in CFA. Macroscopic clinical evidence of CIA first appeared as peri-articular erythema and oedema in the hind paws. The incidence of CIA was 100{\%} by day 27 in the CII challenged rats and the severity of CIA progressed over a 35-day period with radiographic evaluation revealing focal resorption of bone together with osteophyte formation in the tibiotarsal joint and soft tissue swelling. 4. The histopathology of CIA included erosion of the cartilage at the joint margins. Treatment of rats with cloricromene (10 mg kg -1 i.p. daily) starting at the onset of arthritis (day 23), delayed the development of the clinical signs at days 24-35 and improved histological status in the knee and paw. 5. Immunohistochemical analysis for iNOS, COX-2, nitrotyrosine and for poly (ADP-ribose) synthetase (PARS) revealed a positive staining in inflamed joints from collagen-treated rats. The degree of staining for iNOS, COX-2, nitrotyrosine and PARS were markedly reduced in tissue sections obtained from collagen-treated rats, which had received cloricromene. 6. Radiographic signs of protection against bone resorption and osteophyte formation were present in the joints of cloricromene-treated rat. 7. This study provides the first evidence that cloricromene, a coumarine derivative, attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in the rat.",
keywords = "Cloricromene, Collagen, COX-2, Inflammation, Nitric oxide, Peroxynitrite, TNFα",
author = "Salvatore Cuzzocrea and Emanuela Mazzon and Carla Bevilaqua and Giuseppina Costantino and Domenico Britti and Giuseppe Mazzullo and {De Sarro}, Angela and Caputi, {Achille P.}",
year = "2000",
language = "English",
volume = "131",
pages = "1399--1407",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats

AU - Cuzzocrea, Salvatore

AU - Mazzon, Emanuela

AU - Bevilaqua, Carla

AU - Costantino, Giuseppina

AU - Britti, Domenico

AU - Mazzullo, Giuseppe

AU - De Sarro, Angela

AU - Caputi, Achille P.

PY - 2000

Y1 - 2000

N2 - 1. The aim of the present stud), was to investigate the effects of cloricromene, a coumarine derivative, in rats subjected to collagen-induced arthritis. 2. Collagen-induced arthritis (CIA) was induced in Lewis rats by an intradermal injection of 100 μl of the emulsion (containing 100 μg of bovine type II collagen) (CII) and complete Freund's adjuvant (CFA) at the base of the tail. On day 21, a second injection of CII in CFA was administered. 3. Lewis rats developed an erosive hind paw arthritis when immunized with CII in CFA. Macroscopic clinical evidence of CIA first appeared as peri-articular erythema and oedema in the hind paws. The incidence of CIA was 100% by day 27 in the CII challenged rats and the severity of CIA progressed over a 35-day period with radiographic evaluation revealing focal resorption of bone together with osteophyte formation in the tibiotarsal joint and soft tissue swelling. 4. The histopathology of CIA included erosion of the cartilage at the joint margins. Treatment of rats with cloricromene (10 mg kg -1 i.p. daily) starting at the onset of arthritis (day 23), delayed the development of the clinical signs at days 24-35 and improved histological status in the knee and paw. 5. Immunohistochemical analysis for iNOS, COX-2, nitrotyrosine and for poly (ADP-ribose) synthetase (PARS) revealed a positive staining in inflamed joints from collagen-treated rats. The degree of staining for iNOS, COX-2, nitrotyrosine and PARS were markedly reduced in tissue sections obtained from collagen-treated rats, which had received cloricromene. 6. Radiographic signs of protection against bone resorption and osteophyte formation were present in the joints of cloricromene-treated rat. 7. This study provides the first evidence that cloricromene, a coumarine derivative, attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in the rat.

AB - 1. The aim of the present stud), was to investigate the effects of cloricromene, a coumarine derivative, in rats subjected to collagen-induced arthritis. 2. Collagen-induced arthritis (CIA) was induced in Lewis rats by an intradermal injection of 100 μl of the emulsion (containing 100 μg of bovine type II collagen) (CII) and complete Freund's adjuvant (CFA) at the base of the tail. On day 21, a second injection of CII in CFA was administered. 3. Lewis rats developed an erosive hind paw arthritis when immunized with CII in CFA. Macroscopic clinical evidence of CIA first appeared as peri-articular erythema and oedema in the hind paws. The incidence of CIA was 100% by day 27 in the CII challenged rats and the severity of CIA progressed over a 35-day period with radiographic evaluation revealing focal resorption of bone together with osteophyte formation in the tibiotarsal joint and soft tissue swelling. 4. The histopathology of CIA included erosion of the cartilage at the joint margins. Treatment of rats with cloricromene (10 mg kg -1 i.p. daily) starting at the onset of arthritis (day 23), delayed the development of the clinical signs at days 24-35 and improved histological status in the knee and paw. 5. Immunohistochemical analysis for iNOS, COX-2, nitrotyrosine and for poly (ADP-ribose) synthetase (PARS) revealed a positive staining in inflamed joints from collagen-treated rats. The degree of staining for iNOS, COX-2, nitrotyrosine and PARS were markedly reduced in tissue sections obtained from collagen-treated rats, which had received cloricromene. 6. Radiographic signs of protection against bone resorption and osteophyte formation were present in the joints of cloricromene-treated rat. 7. This study provides the first evidence that cloricromene, a coumarine derivative, attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in the rat.

KW - Cloricromene

KW - Collagen

KW - COX-2

KW - Inflammation

KW - Nitric oxide

KW - Peroxynitrite

KW - TNFα

UR - http://www.scopus.com/inward/record.url?scp=0033639038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033639038&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 1399

EP - 1407

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -